| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |